Every story in this section, newest first — page 174 of 373.
Bath & Body Works (NYSE:BBWI) reported a 3% decline in net sales for the first quarter of 2026, reflecting a broader normalization of consumer spending within the beauty and home fragrance categories.
Sound Point Meridian Capital (NYSE:SPMC) announced its financial results for the fourth fiscal quarter ended March 31, 2026, reporting a net asset value per share of $9.63 for its common stock.
Dycom Industries (NYSE:DY) reported record financial results for its fiscal first quarter of 2027, driven by strong demand for digital infrastructure deployments.
Manchester United (NYSE:MANU) reported a sharp turnaround in operating profitability for the first nine months of fiscal 2026, fueled by aggressive restructuring initiatives and a successful domestic campaign.
Dick’s Sporting Goods (NYSE:DKS) reported a 62.7% surge in consolidated net sales for the first quarter of 2026, marking its first full quarter of financial consolidation since acquiring Foot Locker.
Movado Group (NYSE:MOV) reported a sharp increase in operating income and profitability metrics for the first quarter of fiscal 2027, driven by higher net sales and improved operational execution across its core wholesale and direct-to-consumer networks.
Capri Holdings (NYSE:CPRI) reported a 3.7% decline in fourth-quarter revenue for fiscal 2026, as the luxury fashion group continued to navigate broader demand headwinds across the global consumer discretionary sector.
Apogee Therapeutics (NASDAQ:APGE) has entered into a strategic financing collaboration with Blackstone Life Sciences, securing up to $1.3 billion in flexible, non-dilutive capital.
Apogee Therapeutics (NASDAQ:APGE) reported positive mid-stage clinical data for its experimental eczema treatment, paving the way for late-stage trials later this year alongside a new multi-indication financing deal with Blackstone Life Sciences.
Stratasys (NASDAQ:SSYS) has entered into a definitive agreement to acquire Markforged, a wholly owned subsidiary of Nano Dimension, in an all-cash transaction valued at $42.5 million.
PDD Holdings (NASDAQ:PDD) reported an 11% increase in revenue for the first quarter of 2026, driven by growth in its transaction services division.
The U.S. Food and Drug Administration has extended its review period for AstraZeneca's (NASDAQ:AZN) New Drug Application for camizestrant, delaying a final decision on the advanced breast cancer treatment.
Kingsoft Cloud Holdings (NASDAQ:KC) reported a 37.2% year-over-year surge in total revenue for the first quarter of 2026, driven by expanding artificial intelligence demand and deeper penetration into enterprise accounts.
ChipMOS TECHNOLOGIES (NASDAQ:IMOS) announced that its shareholders have officially approved a cash dividend distribution from the company’s capital surplus during its Annual General Meeting held on May 26, 2026.
Bank of Montreal (NYSE:BMO) has released its financial results for the second quarter of 2026, posting a reported net income of $2.63 billion.
Colliers (NASDAQ:CIGI) has officially closed its acquisition of Ayesa Engineering, the engineering division of the Seville-based Ayesa Group, marking a significant expansion of the global real estate and investment management firm's technical capabilities.
Sociedad Química y Minera de Chile (NYSE:SQM) reported a sharp rebound in its first-quarter financial results for 2026, driven by an acceleration in electric vehicle battery materials demand that led the producer to raise its full-year delivery guidance.
Aligos Therapeutics (NASDAQ:ALGS) presented a series of clinical and preclinical data packages spanning its liver disease and viral portfolios, highlighting long-term tracking data from its lead drug candidate alongside several pipeline assets.
Gilead Sciences (NASDAQ:GILD) released new results from a post hoc analysis of its open-label Phase 3 ASSURE study, demonstrating that its approved drug Livdelzi (seladelpar) achieved high and sustained rates of normalization in a key biomarker of liver disease progression.
Precision BioSciences (NASDAQ:DTIL) unveiled late-breaking clinical data from its ongoing Phase 1/2a ELIMINATE-B trial, delivering what it characterizes as the first-ever human biopsy evidence of a therapeutic agent successfully eliminating and inactivating the root genetic reservoir of chronic hepatitis B.
Silvercorp Metals (NYSE:SVM reported record revenue for its full fiscal year 2026, driven by a dramatic rally in global silver prices that generated substantial operating cash flow and offset heavy non-cash accounting adjustments.
Hafnia (NYSE:HAFN) reported a near-tripling of its first-quarter net profit for 2026, capitalized on a robust global product tanker market that drove sharp increases in average daily charter rates and expanded operational cash generation.
DigitalBridge Group (NYSE:DBRG) agreed to acquire ArcLight Capital Partners for up to $1.05 billion, bridging the gap between data center operators and the electric grid as artificial intelligence applications trigger unprecedented demands for power.
PodcastOne (NASDAQ:PODC) raised its financial projections for the full fiscal year 2026, driven by an optimized capital structure and preliminary steps to monetize its historical media library through artificial intelligence data-licensing agreements.
